Published in J Clin Microbiol on September 27, 2006
Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland. J Clin Microbiol (2008) 0.94
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol (2000) 34.08
Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell (1984) 31.52
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother (1997) 17.36
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A (2002) 15.85
Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2002) 15.11
Genome and virulence determinants of high virulence community-acquired MRSA. Lancet (2002) 14.64
Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis (2003) 13.83
Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol (2003) 10.68
Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis (2002) 6.18
Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol (1992) 5.99
Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol (1994) 5.62
Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 5.29
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother (2002) 4.83
Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist (2000) 4.24
Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol (2001) 4.18
Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol (1998) 3.79
Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl Environ Microbiol (2003) 3.51
New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J Clin Microbiol (2003) 2.96
Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis (2003) 2.44
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother (2005) 2.34
Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother (1997) 2.17
Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates. J Clin Microbiol (2005) 2.16
Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun (1992) 2.03
Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J Clin Microbiol (2003) 1.96
[Antibiogram Committee of the French Microbiology Society. Report 2000-2001]. Pathol Biol (Paris) (2000) 1.94
Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J Clin Microbiol (2001) 1.88
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis (2004) 1.84
First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Microbiol (2001) 1.69
Wide geographic distribution of a unique methicillin-resistant Staphylococcus aureus clone in Hungarian hospitals. Clin Microbiol Infect (1997) 1.65
Comparison of five agglutination tests for identification of Staphylococcus aureus. J Clin Microbiol (1997) 1.61
Community-associated methicillin-resistant Staphylococcus aureus, Switzerland. Emerg Infect Dis (2005) 1.55
Identification, cloning, and expression of the CAMP factor gene (cfa) of group A streptococci. Infect Immun (1999) 1.39
Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother (1998) 1.39
Prevalence and chromosomal map location of Staphylococcus aureus adhesin genes. Gene (1997) 1.25
Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2004) 1.16
Coagulase deficiency in clinical isolates of Staphylococcus aureus involves both transcriptional and post-transcriptional defects. J Med Microbiol (1994) 1.14
Expression of pls, a gene closely associated with the mecA gene of methicillin-resistant Staphylococcus aureus, prevents bacterial adhesion in vitro. Infect Immun (2001) 1.11
Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains. J Antimicrob Chemother (2005) 1.04
Lysogenic conversion for multiple characters in a strain of Staphylococcus aureus. J Bacteriol (1977) 0.99
Reduced adherence and host cell invasion by methicillin-resistant Staphylococcus aureus expressing the surface protein Pls. J Infect Dis (2004) 0.99
Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II. Antimicrob Agents Chemother (2004) 0.98
Clonal analysis and identification of epidemic strains of methicillin-resistant Staphylococcus aureus by antibiotyping and determination of protein A gene and coagulase gene polymorphisms. J Clin Microbiol (1997) 0.94
Characterization of a Tn925-induced mutant of Staphylococcus aureus altered in exoprotein production. J Basic Microbiol (1994) 0.88
Clonal structure of the methicillin-resistant Staphylococcus aureus (MRSA) population in Poland: revision and update. Microb Drug Resist (2005) 0.84
A Shared noncapsular antigen is responsible for false-positive reactions by Staphylococcus epidermidis in commercial agglutination tests for Staphylococcus aureus. J Clin Microbiol (2001) 0.82
The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland. J Antimicrob Chemother (2002) 0.81
Recombination at the coagulase locus in Staphylococcus aureus: plasmid integration and amplification. J Gen Microbiol (1993) 0.80
Chromosomally-mediated antibiotic resistance and virulence. J Med Microbiol (1994) 0.79
[Evaluation of drug sensitivity and biochemical properties of coagulase-negative S. aureus strains isolated from clinical specimens]. Med Dosw Mikrobiol (1993) 0.77
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis (2013) 3.61
New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J Clin Microbiol (2003) 2.96
Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland. J Antimicrob Chemother (2002) 2.49
Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother (2002) 2.29
Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates. J Clin Microbiol (2005) 2.16
Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol (2007) 1.85
Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol (2008) 1.81
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob Agents Chemother (2009) 1.75
Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J Clin Microbiol (2007) 1.70
Varicella vaccination in Europe - taking the practical approach. BMC Med (2009) 1.63
Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009. Antimicrob Agents Chemother (2011) 1.58
Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries. Antimicrob Agents Chemother (2002) 1.56
High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One (2012) 1.53
Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland. Antimicrob Agents Chemother (2006) 1.42
Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother (2003) 1.37
Two different extended-spectrum beta-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland. J Clin Microbiol (2002) 1.34
Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother (2004) 1.34
Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother (2008) 1.33
First report of Streptococcus pneumoniae serotype 6D isolates from invasive infections. Vaccine (2010) 1.20
International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum beta-lactamases in a Czech hospital. J Clin Microbiol (2009) 1.17
An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth. Infect Immun (2003) 1.16
New selective and differential chromogenic agar medium, chromID VRE, for screening vancomycin-resistant Enterococcus species. J Microbiol Methods (2009) 1.14
A new rapid and cost-effective method for detection of phages, ICEs and virulence factors encoded by Streptococcus pyogenes. Pol J Microbiol (2011) 1.12
Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. Antimicrob Agents Chemother (2002) 1.12
A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother (2004) 1.07
Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland. Antimicrob Agents Chemother (2004) 1.07
Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004). Int J Antimicrob Agents (2008) 1.06
Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. J Clin Microbiol (2006) 1.04
Comparison of PCR-based methods for typing Staphylococcus aureus isolates. J Clin Microbiol (2006) 1.03
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland. Antimicrob Agents Chemother (2007) 1.00
Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Pol J Microbiol (2005) 1.00
The relBE2Spn toxin-antitoxin system of Streptococcus pneumoniae: role in antibiotic tolerance and functional conservation in clinical isolates. PLoS One (2010) 1.00
Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland. J Antimicrob Chemother (2010) 0.99
Two clones of methicillin-resistant Staphylococcus aureus in Poland. Clin Microbiol Infect (1997) 0.99
Evolution of TEM-type extended-spectrum beta-lactamases in clinical Enterobacteriaceae strains in Poland. Antimicrob Agents Chemother (2005) 0.99
Staphylococcal cassette chromosome mec (Sccmec) classification and typing methods: an overview. Pol J Microbiol (2011) 0.98
Molecular surveillance of methicillin-resistant Staphylococcus aureus by multiple-locus variable number tandem repeat fingerprinting (formerly multiple-locus variable number tandem repeat analysis) and spa typing in a hierarchic approach. Diagn Microbiol Infect Dis (2008) 0.95
Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated from the nasopharynges of asymptomatic children and molecular analysis of S. pneumoniae and H. influenzae strain replacement in the nasopharynx. J Clin Microbiol (2004) 0.95
Expansion and evolution of the Streptococcus pneumoniae Spain9V-ST156 clonal complex in Poland. Antimicrob Agents Chemother (2010) 0.94
Clonal structure of Enterococcus faecalis isolated from Polish hospitals: characterization of epidemic clones. J Clin Microbiol (2006) 0.94
Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland. J Clin Microbiol (2008) 0.94
Detection of Streptococcus pyogenes virulence factors by multiplex PCR. Virulence (2012) 0.93
Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol (2006) 0.92
Multilocus variable number tandem repeat analysis (MLVA) of Streptococcus pyogenes. J Microbiol Methods (2011) 0.91
Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. J Antimicrob Chemother (2011) 0.91
Typing of Streptococcus pyogenes strains using the phage profiling method. Virulence (2012) 0.91
Efficiency of the Cepheid Xpert vanA/vanB assay for screening of colonization with vancomycin-resistant enterococci during hospital outbreak. Antonie Van Leeuwenhoek (2011) 0.90
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20. Antimicrob Agents Chemother (2007) 0.90
Usefulness of multiple-locus VNTR fingerprinting in detection of clonality of community- and hospital-acquired Staphylococcus aureus isolates. Antonie Van Leeuwenhoek (2008) 0.89
Intercenter reproducibility of binary typing for Staphylococcus aureus. J Microbiol Methods (2002) 0.89
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrob Agents Chemother (2010) 0.89
The current status of invasive pneumococcal disease in Poland. Vaccine (2010) 0.89
Identification of multidrug-resistant Streptococcus pneumoniae strains isolated in Poland by multilocus sequence typing. Microb Drug Resist (2003) 0.89
Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland. Clin Vaccine Immunol (2006) 0.87
A decade of invasive meningococcal disease surveillance in Poland. PLoS One (2013) 0.87
Phenotypic and molecular analysis of penicillin-nonsusceptible Streptococcus pneumoniae isolates in Poland. Antimicrob Agents Chemother (2006) 0.86
Characteristics of Haemophilus influenzae type b responsible for meningitis in Poland from 1997 to 2004. J Clin Microbiol (2005) 0.84
Clonal structure of the methicillin-resistant Staphylococcus aureus (MRSA) population in Poland: revision and update. Microb Drug Resist (2005) 0.84
Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms. Med Sci Monit (2010) 0.84
Characterization of transcription within sdr region of Staphylococcus aureus. Antonie Van Leeuwenhoek (2010) 0.83
Abundance and diversity of plasmid-associated genes among clinical isolates of Enterococcus faecalis. Plasmid (2013) 0.83
Pyogenic streptococci--danger of re-emerging pathogens. Pol J Microbiol (2010) 0.83
[Alexander Project--5 years in Poland]. Pol Merkur Lekarski (2003) 0.83
Genetic relatedness, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae responsible for meningitis in Poland, 1997-2001. Microb Drug Resist (2003) 0.82
Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia. PLoS One (2013) 0.82
The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland. J Antimicrob Chemother (2002) 0.81
Molecular analysis of Acinetobacter baumannii isolates from invasive infections in 2009 in Poland. J Clin Microbiol (2012) 0.81
The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis. J Microbiol Methods (2003) 0.81
Nosocomial outbreak of Streptococcus pneumoniae Spain9V‑ST156‑14 clone in a pulmonary diseases ward. Pol Arch Med Wewn (2012) 0.81
Automated peritoneal dialysis-associated peritonitis due to Haemophilus influenzae showing the BLNAR phenotype. Int J Infect Dis (2009) 0.80
The effect of an antibiotic policy on the control of vancomycin-resistant enterococci outbreak and on the resistance patterns of bacteria isolated from the blood of patients in a hematology unit. Pol Arch Med Wewn (2009) 0.79
High genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland. Antimicrob Agents Chemother (2005) 0.79
Prevalence and serotype distribution of encapsulated Haemophilus influenzae isolates from patients with lower respiratory tract infections in Poland. J Clin Microbiol (2005) 0.79
Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureus strains. BMC Microbiol (2008) 0.79
[Invasive pneumococcal disease in Poland in 2010]. Pol Merkur Lekarski (2011) 0.78
Complex nature of enterococcal pheromone-responsive plasmids. Pol J Microbiol (2010) 0.78
[European Antibiotic Awareness Day educational campaign--has it changed public attitudes to antibiotic use in Poland?]. Pol Merkur Lekarski (2010) 0.78
[Invasive pneumococcal disease in the Malopolska region of Poland, in the year 2002-2008. Is introduction of mass vaccination with conjugated pneumococcal vaccine justified?]. Med Wieku Rozwoj (2010) 0.77
Invasive meningococcal disease associated with a very high case fatality rate in the North-West of Poland. FEMS Immunol Med Microbiol (2006) 0.77
[Self-medication with antibiotics in Poland]. Pol Merkur Lekarski (2006) 0.77
Gelatinase-associated phenotypes and genotypes among clinical isolates of Enterococcus faecalis in Poland. Pol J Microbiol (2011) 0.76
A novel member of the thermolysin family, cloning and biochemical characterization of metalloprotease from Staphylococcus pseudintermedius. Acta Biochim Pol (2008) 0.76
[Invasive meningococcal disease in Opolskie Voivodeship between 2005-2010]. Pol Merkur Lekarski (2012) 0.76
[Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age]. Pol Merkur Lekarski (2014) 0.75
Multiple locus VNTR fingerprinting (MLVF) of Streptococcus pyogenes. Virulence (2012) 0.75
Susceptibility testing and resistance phenotypes detection in bacterial pathogens using the VITEK 2 System. Pol J Microbiol (2005) 0.75
Comparison of multilocus variable-number tandem-repeat analysis with multilocus sequence typing and pulsed-field gel electrophoresis for Enterococcus faecalis. Pol J Microbiol (2011) 0.75
Streptococcus anginosus (milleri) Group Strains Isolated in Poland (1996-2012) and their Antibiotic Resistance Patterns. Pol J Microbiol (2016) 0.75
Antimicrobial susceptibility of metallo-beta-lactamase positive and negative Klebsiella pneumoniae strains isolated from intensive care unit patients. Pol J Microbiol (2010) 0.75
Significance of Meningococcal Hyperinvasive Clonal Complexes and their Influence on Vaccines Development. Pol J Microbiol (2015) 0.75
[Chlamydia pneumoniae infection in patients with advanced carotid atherosclerosis]. Pol Merkur Lekarski (2004) 0.75
[First isolation of metallo-beta-lactamase producing Klebsiella pneumoniae strain in Poland]. Anestezjol Intens Ter (2010) 0.75
[Peritonitis in the course of peritoneal dialisis caused by Haemophilus influenzae with BLNAR phenotype]. Pol Merkur Lekarski (2009) 0.75
Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia. J Antimicrob Chemother (2008) 0.75
[Incidence of Haemophilus influenzae type b meningitis in children under 5 years from Malopolska region in the years 2003-2004--prospective study]. Med Wieku Rozwoj (2009) 0.75
Usefulness of CHROMagar Candida Medium, Biochemical Methods--API ID32C and VITEK 2 Compact and Two MALDI-TOF MS Systems for Candida spp. Identification. Pol J Microbiol (2016) 0.75
Hospital antibiotic management in Poland--results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr (2008) 0.75